‘The monthly curse’: menstrual-associated coronary artery vasospasm in a premenopausal woman—a case report

During the late luteal and menstrual phases, circulating oestrogen levels decline to their lowest point, potentially increasing susceptibility to coronary vasospasms. In recent years, oestrogen replacement therapy has been reported to confer therapeutic benefits in this patient population. Early multidisciplinary collaboration involving gynaecologists and timely initiation of hormonal therapy may alter the clinical course and prevent fatal outcomes in such patients.